Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 89

    Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

    Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder

    Farhat Nasim28 Aug 2019 2:39 PM IST
    Solifenacin Succinate Tablet is a generic version of Vesicare Tablets of Astellas Pharma US, Unichem said.New Delhi: Drug firm Unichem Laboratories...
    Revised drug law to pave way for cheap Indian generic medicines in China: Report

    Revised drug law to pave way for cheap Indian generic medicines in China: Report

    Medical Dialogues Bureau28 Aug 2019 9:45 AM IST
    India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the USD 57 billion trade deficit in...
    Ipca Labs gets 3 USFDA observations for Silvassa unit

    Ipca Labs gets 3 USFDA observations for Silvassa unit

    Medical Dialogues Bureau28 Aug 2019 9:30 AM IST
    In a regulatory filing to BSE, Ipca Laboratories said the USFDA had conducted the inspection of its formulations manufacturing unit situated at...
    AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

    AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

    Medical Dialogues Bureau28 Aug 2019 9:15 AM IST
    Farxiga, one of AstraZeneca Plc's top 10 drugs by sales, is part of the SGLT2-inhibitor class of antidiabetics that cause the kidneys to expel blood...
    Purdue Pharma offers upto USD 12 billion to settle opioid claims

    Purdue Pharma offers upto USD 12 billion to settle opioid claims

    Farhat Nasim28 Aug 2019 9:00 AM IST
    U.S: OxyContin maker Purdue PharmaLP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the...
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Farhat Nasim27 Aug 2019 2:30 PM IST
    "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Lupin inks commercial pact with Creso Pharma for cannaQIX

    Medical Dialogues Bureau27 Aug 2019 10:00 AM IST
    As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    Medical Dialogues Bureau27 Aug 2019 9:45 AM IST
    Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
    Boehringer Ingelheim to restructure executive board

    Boehringer Ingelheim to restructure executive board

    Medical Dialogues Bureau27 Aug 2019 9:30 AM IST
    Allan Hillgrove, head of pharmaceuticals and biopharma and a company veteran of 37 years, will retire at the end of the year and will be replaced by...
    JnJ directed to pay USD 572 million for opioid addiction crisis

    JnJ directed to pay USD 572 million for opioid addiction crisis

    Medical Dialogues Bureau27 Aug 2019 9:20 AM IST
    Norman (US): An Oklahoma judge on Monday found Johnson and Johnson(JnJ) and its subsidiaries helped fuel the state's opioid drug crisis and ordered...
    Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

    Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla

    Medical Dialogues Bureau27 Aug 2019 9:15 AM IST
    Amgen, which announced the deal on Monday, is paying a hefty price for the drug, analysts and investors said. Still, Otezla will deliver growth for...
    Alkem Labs gets 4 USFDA observations for St Louis facility

    Alkem Labs gets 4 USFDA observations for St Louis facility

    Medical Dialogues Bureau26 Aug 2019 12:39 PM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

    Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok